New Zealand markets closed

Zhejiang Haisen Pharmaceutical Co., Ltd. (001367.SZ)

Shenzhen - Shenzhen Delayed price. Currency in CNY
Add to watchlist
23.34+0.26 (+1.13%)
At close: 03:04PM CST
Currency in CNY

Valuation measures4

Market cap (intra-day) 2.35B
Enterprise value 1.41B
Trailing P/E 20.56
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)5.66
Price/book (mrq)1.83
Enterprise value/revenue 3.46
Enterprise value/EBITDA 10.75

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-24.23%
S&P500 52-week change 322.55%
52-week high 338.51
52-week low 317.94
50-day moving average 325.23
200-day moving average 326.57

Share statistics

Avg vol (3-month) 31.18M
Avg vol (10-day) 3844.83k
Shares outstanding 5100.64M
Implied shares outstanding 6102.92M
Float 825.16M
% held by insiders 178.33%
% held by institutions 10.58%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.5
Forward annual dividend yield 42.14%
Trailing annual dividend rate 30.34
Trailing annual dividend yield 31.46%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 418 Jun 2024
Last split factor 21.48:1
Last split date 318 Jun 2024

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 27.83%
Operating margin (ttm)28.73%

Management effectiveness

Return on assets (ttm)7.33%
Return on equity (ttm)12.91%

Income statement

Revenue (ttm)406.3M
Revenue per share (ttm)4.12
Quarterly revenue growth (yoy)8.30%
Gross profit (ttm)N/A
EBITDA 117.57M
Net income avi to common (ttm)113.05M
Diluted EPS (ttm)1.13
Quarterly earnings growth (yoy)33.60%

Balance sheet

Total cash (mrq)951.78M
Total cash per share (mrq)9.46
Total debt (mrq)8.88M
Total debt/equity (mrq)0.69%
Current ratio (mrq)22.78
Book value per share (mrq)12.75

Cash flow statement

Operating cash flow (ttm)98.91M
Levered free cash flow (ttm)-18.41M